Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/jhh.2017.61 http://scihub22266oqcxt.onion/10.1038/jhh.2017.61 C5680413!5680413 !29115294     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\29115294 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       J+Hum+Hypertens 2017 ; 31 (12 ): 782-786 Nephropedia Template TP {{tp|p=29115294 |t=2017. Placental growth factor and pre-eclampsia |pdf=|usr=}}{{29115294 }} gab.com Text Placental growth factor and pre-eclampsia JO: J Hum Hypertens http://www.kidney.de/pget.php?&tw=1&pmid=29115294 #FOAvip Placental growth factor (PlGF) is an increasingly important molecule in the prediction, diagnosis and treatment of pre-eclampsia. It has pro-angiogenic effects on the feto-placental circulation and supports trophoblast growth. Mechanisms by which PlGF expression is regulated continue to be investigated. Low circulating PlGF precedes the manifestation of clinical disease in pre-eclamptic pregnancies and intrauterine growth restriction. This suggests that low PlGF is a marker of abnormal placentation, but it remains uncertain whether this is a cause or consequence. Prediction of pre-eclampsia using PlGF is promising and may assist in the targeting of resources to women at highest risk of adverse pregnancy outcomes. Promisingly, experimental animal models of pre-eclampsia have been successfully treated with supplemental PlGF. Treatment of pre-eclampsia with PlGF is a potential therapeutic option requiring further exploration. This review focuses specifically on the role of PlGF in normal and pathological placental development and in the clinical management of pre-eclampsia. Twit Text FOAVip Placental growth factor and pre-eclampsia ????J Hum Hypertens http://www.kidney.de/pget.php?&tw=1&pmid=29115294 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29115294 #FOAvip English Wikipedia <ref>{{Cite pmid|29115294 }}</ref> Placental growth factor and pre-eclampsia #MMPMID29115294 Chau K ; Hennessy A ; Makris A J Hum Hypertens 2017[Dec]; 31 (12 ): 782-786 PMID29115294 show ga Placental growth factor (PlGF) is an increasingly important molecule in the prediction, diagnosis and treatment of pre-eclampsia. It has pro-angiogenic effects on the feto-placental circulation and supports trophoblast growth. Mechanisms by which PlGF expression is regulated continue to be investigated. Low circulating PlGF precedes the manifestation of clinical disease in pre-eclamptic pregnancies and intrauterine growth restriction. This suggests that low PlGF is a marker of abnormal placentation, but it remains uncertain whether this is a cause or consequence. Prediction of pre-eclampsia using PlGF is promising and may assist in the targeting of resources to women at highest risk of adverse pregnancy outcomes. Promisingly, experimental animal models of pre-eclampsia have been successfully treated with supplemental PlGF. Treatment of pre-eclampsia with PlGF is a potential therapeutic option requiring further exploration. This review focuses specifically on the role of PlGF in normal and pathological placental development and in the clinical management of pre-eclampsia. |*Placentation [MESH] |Animals [MESH] |Female [MESH] |Humans [MESH] |Neovascularization, Physiologic [MESH] |Placenta Growth Factor/*physiology/therapeutic use [MESH] |Pre-Eclampsia/*blood/diagnosis/drug therapy [MESH]Placental growth factor and pre-eclampsia (epmc).pdf DeepDyve Pubget Overpricing